472 related articles for article (PubMed ID: 25897487)
1. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
Pettersson N; Nyman J; Johansson KA
Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
[TBL] [Abstract][Full Text] [Related]
3. Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors.
Kim SS; Song SY; Kwak J; Ahn SD; Kim JH; Lee JS; Kim WS; Kim SW; Choi EK
Lung Cancer; 2013 Feb; 79(2):161-6. PubMed ID: 23182662
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship.
Asai K; Shioyama Y; Nakamura K; Sasaki T; Ohga S; Nonoshita T; Yoshitake T; Ohnishi K; Terashima K; Matsumoto K; Hirata H; Honda H
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):768-73. PubMed ID: 22445398
[TBL] [Abstract][Full Text] [Related]
5. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer.
Bongers EM; Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
J Thorac Oncol; 2011 Dec; 6(12):2052-7. PubMed ID: 22052227
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
[TBL] [Abstract][Full Text] [Related]
8. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
Dunlap NE; Cai J; Biedermann GB; Yang W; Benedict SH; Sheng K; Schefter TE; Kavanagh BD; Larner JM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):796-801. PubMed ID: 19427740
[TBL] [Abstract][Full Text] [Related]
9. Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.
Park Y; Kim HJ; Chang AR
Radiat Oncol; 2017 Apr; 12(1):66. PubMed ID: 28381302
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Chest Wall Toxicity During Long-term Follow Up After Thoracic Stereotactic Body Radiation Therapy.
Chipko C; Ojwang J; Gharai LR; Deng X; Mukhopadhyay N; Weiss E
Pract Radiat Oncol; 2019 May; 9(3):e338-e346. PubMed ID: 30731275
[TBL] [Abstract][Full Text] [Related]
11. Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy.
Taremi M; Hope A; Lindsay P; Dahele M; Fung S; Purdie TG; Jaffray D; Dawson L; Bezjak A
Radiat Oncol; 2012 Sep; 7():159. PubMed ID: 22985910
[TBL] [Abstract][Full Text] [Related]
12. Possibility of chest wall dose reduction using volumetric-modulated arc therapy (VMAT) in radiation-induced rib fracture cases: comparison with stereotactic body radiation therapy (SBRT).
Murakami Y; Nakano M; Yoshida M; Hirashima H; Nakamura F; Fukunaga J; Hirose TA; Yoshioka Y; Oguchi M; Hirata H
J Radiat Res; 2018 May; 59(3):327-332. PubMed ID: 29800456
[TBL] [Abstract][Full Text] [Related]
13. A cortical thickness and radiation dose mapping approach identifies early thinning of ribs after stereotactic body radiation therapy.
Okoukoni C; Lynch SK; McTyre ER; Randolph DM; Weaver AA; Blackstock AW; Lally BE; Munley MT; Willey JS
Radiother Oncol; 2016 Jun; 119(3):449-53. PubMed ID: 27072937
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.
Thibault I; Chiang A; Erler D; Yeung L; Poon I; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):28-35. PubMed ID: 26129745
[TBL] [Abstract][Full Text] [Related]
15. Late chest wall toxicity after MammoSite breast brachytherapy.
Brashears JH; Dragun AE; Jenrette JM
Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
[TBL] [Abstract][Full Text] [Related]
16. Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer.
Abe T; Shirai K; Saitoh J; Ebara T; Shimada H; Tashiro M; Okano N; Ohno T; Nakano T
Acta Oncol; 2016; 55(2):163-6. PubMed ID: 26399488
[TBL] [Abstract][Full Text] [Related]
17. Dose-effect analysis of radiation induced rib fractures after thoracic SBRT.
Stam B; van der Bijl E; Peulen H; Rossi MMG; Belderbos JSA; Sonke JJ
Radiother Oncol; 2017 May; 123(2):176-181. PubMed ID: 28110960
[TBL] [Abstract][Full Text] [Related]
18. Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors.
Nambu A; Onishi H; Aoki S; Tominaga L; Kuriyama K; Araya M; Saito R; Maehata Y; Komiyama T; Marino K; Koshiishi T; Sawada E; Araki T
BMC Cancer; 2013 Feb; 13():68. PubMed ID: 23391264
[TBL] [Abstract][Full Text] [Related]
19. Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review.
Rodríguez-Ruiz ME; San Miguel I; Gil-Bazo I; Perez-Gracia JL; Arbea L; Moreno-Jimenez M; Aristu J
Radiat Oncol; 2012 Mar; 7():50. PubMed ID: 22455311
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
